glp-1 obesity drugs pipeline Novo Nordisk vs Eli Lilly: Who's Winning the Drug Race? GLP Agonist Clinical Trial Pipeline
Description
2025, doi: 10.1111/dom.16661
Front Endocrinol (Lausanne) (2022) 13:787876
Real-world Evidence on the Utilization, Clinical and Comparative Effectiveness, and Adverse Effects of Newer GLP-1RA-based Weight-loss Therapies
Ginger supplements (250 mg four times daily) offer a natural alternative with moderate evidence supporting their antiemetic properties, though patients on blood thinners should consult their provider before use
Proinflammatory environment and role of TNF- in endometrial function of obese women having polycystic ovarian syndrome
Why Hair Loss Can Feel Worse Than It Is Hair loss associated with weight loss often all over rather than in one specific area
